Sentinel Lymph Node Mapping in Breast Cancer

ONCOLOGY

Volumn 13, Issue 1, 1999, Pages 25-34

  Cody III, Hiram S ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLA; BIOPSY; BREAST TUMOR; CANCER INVASION; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; REVIEW; SCINTISCANNING;

AXILLA; BIOPSY; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 0032604667     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Petrek JA, Blackwood MM: Axillary dissection: Current practice and technique. Curr Probl Surg 32:259-323, 1995.
2. Sappey PC: Anatomie, Physiologie, Pathologie des Vesseaux Lymphatiques Consideres chez l'Homme et les Vertebres. Paris, A. Delahaye and E. Lecrosnier, 1885.
3. Halsted WS: The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Rep 4:297-350, 1894.
4. Turner-Warwick RT: The lymphatics of the breast. Br J Surg 46:574-582, 1959.
5. Halsell JT, Smith JR, Bentlage CR, et al: Lymphatic drainage of the breast demonstrated by vital dye staining and radiography. Ann Surg 162:221-226, 1965.
6. Kett K, Varga G, Lukacs L: Direct lymphography of the breast. Lymphology 1:3-12, 1970.
7. Borgstein P, Meijer S: Historical perspective of lymphatic tumour spread and the emergence of the sentinel node concept. Eur J Surg Oncol 24:85-89, 1998.
8. Cabanas R: An approach for the treatment of penile carcinoma. Cancer 39:456-466, 1977.
9. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992.
10. Brady MS, Coit DG: Sentinel lymph node evaluation in melanoma. Arch Dermatol 133:1014-1020, 1997.
11. Krag DN, Weaver DL, Alex JC, et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-340, 1993.
12. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401, 1994.
13. Veronesi U, Paganelli G, Galimberti V, et al: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864-1867, 1997.
14. Pijpers R, Hoekstra OS, Collet GJ, et al: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38:366-368. 1997.
15. Roumen RMH, Valkenburg JGM, Geuskens LM: Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 23:495-502, 1997.
16. Galimberti V, Zurrida S, Zucali P, et al: Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? Breast J 7:8-10, 1998.
17. Borgstein PJ, Pijpers R, Comans EF, et al: Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275-283, 1998.
18. Krag DN, Ashikaga T, Harlow SP, et al: Development of sentinel node targeting technique in breast cancer patients. Breast J 4:67-74, 1998.
19. Offodile R, Hoh C, Barsky SH, et al: Minimally invasive breast cancer staging using lymphatic mapping with radiolabeled dextran. Cancer 82:1704-1708, 1998.
20. Giuliano AE, Jones RC, Brennan M, et al: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345-2350, 1997.
21. Guenther JM, Krishnamoorthy M, Tan LR: Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 3:336-340, 1997.
22. Flett MM, Going JJ, Stanton PD, et al: Sentinel node localization in patients with breast cancer. Br J Surg 85:991-993, 1998.
23. Albertini JJ, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822, 1996.
24. Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 349:1668-1669, 1997.
25. O'Hea BJ, Hill ADK, El-Shirbiny A, et al: Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 186:423-427, 1998.
26. Barnwell JM, Arredondo MA, Kollmorgen D, et al: Sentinel node biopsy in breast cancer. Ann Surg Oncol 5:126-130, 1998.
27. Turner RR, Ollila DW, Krasne DL, et al: Histologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226:271-278, 1997.
28. Linehan DC, Hill ADK, Tran KN, et al: Sentinel lymph node localization in breast cancer: unfiltered isotope is superior to filtered (abstract). SSO Cancer Symposium, p 51, 1998.
29. Gershenwald JE, Colome MI, Lee JE, et al: Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16:2253-2260, 1998.
30. Ollila DW, Giuliano AE: Intraoperative lymphatic mapping and sentinel lymphadenectomy using isosulfan blue dye. Breast Diseases 8:297-300, 1998.
31. International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancer 335:1565-1568, 1990.
32. DeMascarel I, Bonichon F, Coindre JM, et al: Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: Reevaluation with longer follow-up. Br J Cancer 66:523-527, 1992.
33. Hainsworth PJ, Tjandra JJ, Stillwell RG, et al: Detection and significance of occult micrometastases in node-negative breast cancer. Br J Surg 80:459-463, 1993.
34. Veronesi U, Cascinelli N, Bufalino R: Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 198:681-684, 1983.
35. Cody HS, Urban JA: Internal mammary node status: A major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 2:32-37, 1995.
36. McNeil C: Four large studies aim to resolve sentinel node debate. J Natl Cancer Inst 90:729, 1998.
37. Fisher B: Laboratory and clinical research in breast cancer: A personal adventure: The David A. Karnofsky memorial lecture. Cancer Res 40:3863-3874, 1980.